chr16-47587662-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000293.3(PHKB):​c.775-6G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0522 in 1,607,860 control chromosomes in the GnomAD database, including 5,304 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 2299 hom., cov: 32)
Exomes 𝑓: 0.045 ( 3005 hom. )

Consequence

PHKB
NM_000293.3 splice_region, intron

Scores

2
Splicing: ADA: 0.000006794
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.61

Publications

4 publications found
Variant links:
Genes affected
PHKB (HGNC:8927): (phosphorylase kinase regulatory subunit beta) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, encoded by this gene, which is a member of the phosphorylase b kinase regulatory subunit family. The gamma subunit also includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9B, also known as phosphorylase kinase deficiency of liver and muscle. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. Two pseudogenes have been found on chromosomes 14 and 20, respectively.[provided by RefSeq, Feb 2010]
PHKB Gene-Disease associations (from GenCC):
  • glycogen storage disease IXb
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-47587662-G-C is Benign according to our data. Variant chr16-47587662-G-C is described in ClinVar as Benign. ClinVar VariationId is 257179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKBNM_000293.3 linkc.775-6G>C splice_region_variant, intron_variant Intron 8 of 30 ENST00000323584.10 NP_000284.1 Q93100-1
PHKBNM_001363837.1 linkc.775-6G>C splice_region_variant, intron_variant Intron 8 of 30 NP_001350766.1
PHKBNM_001031835.3 linkc.754-6G>C splice_region_variant, intron_variant Intron 9 of 31 NP_001027005.1 Q93100-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKBENST00000323584.10 linkc.775-6G>C splice_region_variant, intron_variant Intron 8 of 30 1 NM_000293.3 ENSP00000313504.5 Q93100-1

Frequencies

GnomAD3 genomes
AF:
0.117
AC:
17776
AN:
151912
Hom.:
2278
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.322
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0623
Gnomad ASJ
AF:
0.0317
Gnomad EAS
AF:
0.0137
Gnomad SAS
AF:
0.0291
Gnomad FIN
AF:
0.0183
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0412
Gnomad OTH
AF:
0.0982
GnomAD2 exomes
AF:
0.0524
AC:
13140
AN:
250894
AF XY:
0.0477
show subpopulations
Gnomad AFR exome
AF:
0.324
Gnomad AMR exome
AF:
0.0356
Gnomad ASJ exome
AF:
0.0299
Gnomad EAS exome
AF:
0.0141
Gnomad FIN exome
AF:
0.0163
Gnomad NFE exome
AF:
0.0410
Gnomad OTH exome
AF:
0.0425
GnomAD4 exome
AF:
0.0454
AC:
66063
AN:
1455830
Hom.:
3005
Cov.:
28
AF XY:
0.0440
AC XY:
31900
AN XY:
724696
show subpopulations
African (AFR)
AF:
0.324
AC:
10776
AN:
33288
American (AMR)
AF:
0.0389
AC:
1737
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.0306
AC:
798
AN:
26088
East Asian (EAS)
AF:
0.00772
AC:
306
AN:
39648
South Asian (SAS)
AF:
0.0267
AC:
2297
AN:
86110
European-Finnish (FIN)
AF:
0.0156
AC:
830
AN:
53304
Middle Eastern (MID)
AF:
0.0643
AC:
370
AN:
5758
European-Non Finnish (NFE)
AF:
0.0413
AC:
45668
AN:
1106820
Other (OTH)
AF:
0.0545
AC:
3281
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2556
5112
7667
10223
12779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1832
3664
5496
7328
9160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.117
AC:
17840
AN:
152030
Hom.:
2299
Cov.:
32
AF XY:
0.114
AC XY:
8457
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.322
AC:
13350
AN:
41424
American (AMR)
AF:
0.0621
AC:
948
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0317
AC:
110
AN:
3468
East Asian (EAS)
AF:
0.0135
AC:
70
AN:
5184
South Asian (SAS)
AF:
0.0285
AC:
137
AN:
4806
European-Finnish (FIN)
AF:
0.0183
AC:
193
AN:
10572
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0412
AC:
2802
AN:
67996
Other (OTH)
AF:
0.0981
AC:
207
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
670
1340
2011
2681
3351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0611
Hom.:
202
Bravo
AF:
0.129
Asia WGS
AF:
0.0390
AC:
137
AN:
3478
EpiCase
AF:
0.0480
EpiControl
AF:
0.0470

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Glycogen storage disease IXb Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 13, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.5
DANN
Benign
0.60
PhyloP100
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000068
dbscSNV1_RF
Benign
0.0080
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56268318; hg19: chr16-47621573; API